DUBLIN–(BUSINESS WIRE)–The “Exosome Diagnostics, Therapeutics and Research Tools: Global Markets” report has been added to ResearchAndMarkets.com’s offering.
The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.
The global market for exosome diagnostics and therapeutics saw revenue data amounting to a significant figure in 2021-2022, with estimates for 2023 and forecasts for 2024 projecting robust growth. The market is expected to witness a strong compound annual growth rate (CAGR) through 2028. This analysis provides a comprehensive estimate of the current market size and revenue growth prospects, alongside a detailed market share analysis based on product, application, end user, and region.
Market Drivers, Opportunities, and Restraints
Key market drivers include the growing application of exosome diagnostics in personalized medicine and the rising prevalence of chronic diseases. Opportunities abound in the expanding research activities related to exosomes and their therapeutic potential. However, market growth is restrained by factors such as high costs associated with exosome isolation and the complexity of regulatory pathways. Macroeconomic variables also play a crucial role in shaping the market dynamics.
Emerging Technologies, Regulations, and R&D Efforts
The market is experiencing significant advancements in emerging technologies related to exosome diagnostics and therapeutics. There is a strong emphasis on regulatory frameworks and R&D efforts aimed at enhancing the efficacy and safety of exosome-based products. These developments are crucial in facilitating new commercial opportunities in diagnostics, therapeutics, and research tools markets.
Commercial Opportunities and Trends
New commercial opportunities are emerging in the diagnostics, therapeutics, and research tools markets. Trends such as the development of novel assay technologies and innovative products are driving market growth. The use of exosome proteins and nucleic acids as diagnostic biomarkers is gaining traction, particularly in microRNA, liquid biopsy, and stem cell research industries.
Patent Analysis and Sustainability Trends
Relevant patents in the U.S., Europe, and Japan are analyzed to provide insights into the technological advancements and intellectual property landscape in exosome diagnostics and therapeutics. Additionally, sustainability trends and ESG developments are reviewed, highlighting consumer attitudes, companies’ ESG score rankings, and their sustainability practices.
Competitive Landscape
The competitive landscape is thoroughly analyzed, including companies’ market shares, business segments, financials, and product portfolios. Recent mergers and acquisitions (M&A) activity and a venture funding outlook are also discussed, providing a clear picture of the industry’s competitive dynamics. Company profiles of major players such as Bio-Techne, Exosomics S.p.A., and System Biosciences LLC are included to offer detailed insights into their strategies and market positioning.
Company Profiles
- Acousort Ab
- Aegle Therapeutics
- Aethlon Medical Inc.
- Aruna Bio Inc.
- Bio-Techne
- Capricor Therapeutics Inc.
- Caris Life Sciences
- Direct Biologics Llc
- Exosomics Spa
- Evox Therapeutics Ltd.
- Kimera Labs
- Lonza
- Mir Scientific
- Nano Med
- Nanosomix
- Rion
- System Biosciences Llc
Key Topics Covered:
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Exosome Basics
- Exosome Biogenesis and Processing
- Exosome Function and Physiology
- Intracellular Communication
- Facilitation of the Immune Response
- Tissue Regeneration
- Bioinformatic Databases for Exosome Research and Product Development
- ExoCarta
- Vesiclepedia
- EVpedia
Chapter 3 Market Dynamics
- Overview
- Market Drivers
- Increasing Investment in Biomedical Research
- Trend Towards Precision Medicine
- Technological Advancements in Exosome Research Tools
- Restraints
- Evolving Regulatory Landscape
- Lack of Well-Characterized Exosome Standards
- Opportunities
- Growing Popularity in Liquid Biopsy
- Benefits Over Stem Cell Therapy
- Challenges
- Funding Issues
Chapter 4 Regulatory Landscape
- U.S.
- Exosome Therapeutics
- Exosome Clinical Assays Development and Marketing
Chapter 5 Emerging Technologies and Developments
- Emerging Technologies
- Engineered Exosomes
- Microfluidic Technology
- Exosome Research Services
- Exosome Based Liquid Biopsy Tests
- Clinical Trial Analysis
- Overview
- By Phases
- By Funder Type
- By Disease Type
- By Country
- Pipeline Analysis
Chapter 6 Market Segmentation Analysis
- Segmental Breakdown
- Market Analysis by Application Type
- Diagnostics and Monitoring
- Evaluation of the Diagnostics and Monitoring Market
- Cancer
- CNS Disorders and Neurodegeneration Diseases
- Organ Transplantation
- Cardiovascular Diseases
- Others
- Diagnostics and Monitoring Market Revenue
- Exosome Therapeutics
- Potential Therapeutic Applications
- Evaluation of the Current and Potential Therapeutics Market
- Key Target Indications
- Research Tools and Regents
- Research Tools and Reagents Market Revenue
- Geographic Breakdown
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
Chapter 7 Competitive Intelligence
- Overview
- Exosome-Based Clinical Diagnostics Market
- Market Participants in the Exosome-Based Clinical Diagnostics Market
- Exosome-Based Therapeutics Market
- Market Participants in the Exosome-Based Therapeutics Market
- Exosome Research Tools and Reagents Market
- Market Participants in the Exosome Research Tools and Reagents Market
- Key Strategies
- Opportunities and Challenges in the Exosome Market
Chapter 8 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/goynks
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900